Drugs / stromal vascular fraction
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07629245 | Dec 2025 → Jun 2028 expected | Crohn disease | Assistance Publique Hopitaux De Marseille | Recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | stromal vascular fraction | “Tolerance of Local Administration of Cryopreserved Autologous Stromal Vascular Fraction Combined With Micrograft for the Treatment of Refractory Ano-perineal Fistulas in Crohn's Disease” NCT07629245 ↗ |
| Known as | SVF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07629245 ↗ |
| Modality | Cell therapy | “Cryopreserved Autologous Stromal Vascular Fraction” NCT07629245 ↗ |
| Route | Other | “Local Administration” NCT07629245 ↗ |